Analyst Research

Report Title Price
Provider : Pechala's Reports
Provider : Pechala's Reports
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Heat Biologics Inc Announces Partial Exercise of Underwriters' Over-Allotment Option

Wednesday, 4 Sep 2013 12:55pm EDT 

Heat Biologics Inc announced the partial exercise of the over-allotment option granted to the underwriters to purchase an additional 100,000 shares of its common stock, at a price to the public of $10.00 per share. The overallotment option was granted in connection with the Company's recently announced underwritten public offering of 2,500,000 shares of common stock. The underwriters previously exercised their option to purchase 100,000 shares of common stock of the Company. The total gross proceeds to the Company from the offering, including the underwriters' exercise of their over-allotment option, to be received will be $27,000,000, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. Aegis Capital Corp. acted as sole book-running manager for the offering. Cantor Fitzgerald & Co. acted as a co-manager for the offering. 

Company Quote

0.04 +0.63%
31 Jul 2015